Paracetamol is one of the most widely used pain relievers and fever reducers on Earth, sold under the brand name Tylenol in the United States and Canada (where it goes by its other chemical name, acetaminophen) and under dozens of other names elsewhere. Despite being a medicine cabinet staple for decades, the way paracetamol actually works remains genuinely unresolved. Researchers have proposed multiple mechanisms, from enzyme inhibition in the brain to a metabolite that interacts with the body’s own cannabinoid system, and the honest scientific picture is that several of these pathways probably contribute at once.
Two Names, One Drug
If you have ever been confused by the terms “paracetamol” and “acetaminophen,” the explanation is simple chemistry nomenclature. Both names derive from the same molecule’s full chemical name, para-acetylaminophenol. “Paracetamol” is the standard term in most of the world, including Europe, Asia, Africa, and Australia. “Acetaminophen” is used primarily in the United States, Canada, and Japan. They are the same compound at the same dose, and any study citing one applies equally to the other.
The drug’s history is surprisingly messy. Its discovery in the late 1800s began with what researchers have described as an error involving a compound initially tested for its effects against intestinal worms, and its path to widespread use involved a series of false assumptions about the safety of a related drug, phenacetin, which was later linked to kidney damage.1PubMed. Acetaminophen/paracetamol: A history of errors, failures and false decisions Paracetamol eventually replaced phenacetin and became the default recommendation for mild to moderate pain and fever, especially in people who cannot take anti-inflammatory drugs like ibuprofen or aspirin.
The Mystery of How It Actually Works
Most common painkillers have a well-understood mechanism. Ibuprofen and aspirin block enzymes called COX-1 and COX-2, which are involved in producing prostaglandins, the chemical messengers that cause inflammation, pain, and fever. Paracetamol was long assumed to work the same way, and early laboratory work suggested it might selectively inhibit COX-2. But when researchers tested this directly, paracetamol showed low potency against both COX-1 and COX-2 in lab assays, making the standard COX-inhibition story a poor fit.2PubMed Central. Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action
This is why paracetamol behaves so differently from drugs like ibuprofen in practice. It reduces pain and fever but does almost nothing for inflammation. If you twist your ankle and it swells up, paracetamol can help with the pain but will not reduce the swelling the way an anti-inflammatory would. That clinical profile has always been a clue that something besides simple COX inhibition is going on.
The COX-3 Hypothesis
In the early 2000s, a splice variant of the COX-1 enzyme was identified in dog brain tissue and dubbed “COX-3.” Some researchers proposed that paracetamol works by inhibiting this brain-specific enzyme, which would explain why the drug acts centrally (in the brain and spinal cord) rather than at the site of injury. One influential study supported the idea that paracetamol’s pain-relieving and temperature-lowering effects are mediated by COX-3 inhibition.3PubMed. COX-3 and the mechanism of action of paracetamol/acetaminophen The hypothesis was attractive because it would have neatly explained the drug’s unusual profile.
The problem is that a functionally equivalent COX-3 enzyme has never been found in humans. Subsequent analysis concluded that a physiologically functional COX-3 isoform has not been sequenced in human tissue, effectively ruling it out as paracetamol’s main target in people.4PubMed Central. Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition? The COX-3 idea still occasionally appears in older textbooks and some clinical references, but most pharmacologists now consider it a dead end for explaining how paracetamol works in humans.
The Cannabinoid Connection
The most actively researched explanation involves a metabolite called AM404. When your body processes paracetamol, a portion of it is converted in the brain and nervous system into AM404, a compound that activates a pain-sensing channel called TRPV1 and interacts with the body’s endocannabinoid system. In the brain’s pain-processing regions, AM404 triggers a signaling cascade that ultimately activates cannabinoid CB1 receptors, the same receptors targeted by cannabis compounds, though through an indirect route.5PubMed Central. An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact
Animal research supports this pathway. When the enzyme responsible for converting paracetamol into AM404 (called FAAH) is blocked, paracetamol’s pain-relieving effect disappears. This suggests that the drug itself is not the active painkiller; the metabolite it produces in the brain is.6PubMed. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia A 2025 study added another layer, showing that AM404 is also produced by sensory neurons outside the brain and can directly block sodium channels involved in pain signaling, suggesting the drug may have peripheral effects as well, not just central ones.7PubMed Central. The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels
Serotonin Pathways
The cannabinoid story does not end with CB1 receptors. The same research that identified the FAAH-AM404-CB1 chain also found that the endocannabinoid activation strengthens serotonin-based pain suppression pathways running from the brainstem down the spinal cord.6PubMed. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia When spinal serotonin is depleted experimentally, paracetamol loses both its pain-relieving and its pain-sensitivity-reducing effects entirely.8PubMed. Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT₇ receptors Human studies have confirmed this, showing that a serotonin-blocking drug can abolish paracetamol’s analgesic effect in healthy volunteers.9PubMed. Acetaminophen reinforces descending inhibitory pain pathways
The current picture, then, is that paracetamol probably relieves pain through a multi-step chain: it gets converted into AM404, which activates cannabinoid receptors in the brain’s pain centers, which in turn ramp up serotonin signals that suppress pain at the spinal cord level. There may be additional COX-related effects in the brain at therapeutic doses, but the AM404-cannabinoid-serotonin pathway is where most of the recent research has converged.
How It Lowers Fever
Paracetamol’s fever-reducing effect is somewhat better understood than its pain relief, even though it likely works through overlapping mechanisms. When you are sick, immune signals prompt the brain’s hypothalamus to raise the body’s temperature set-point by producing prostaglandins locally. Paracetamol appears to inhibit prostaglandin production within the central nervous system, which resets the hypothalamic thermostat back toward normal.10PubMed. Paracetamol in fever in critically ill patients-an update This is why it brings down a fever but does not lower your temperature below normal. If you take paracetamol when you do not have a fever, your body temperature stays about where it was.
What Happens When Your Body Processes It
At normal doses, the liver handles paracetamol efficiently. Most of the drug gets converted into harmless compounds through two main chemical pathways and is then flushed out through the kidneys. Only a small fraction goes through a third pathway, run by certain liver enzymes, that produces a reactive and toxic byproduct called NAPQI.11PubMed Central. PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses Under normal circumstances, the body immediately neutralizes NAPQI using an antioxidant called glutathione, and no damage occurs. Paracetamol’s half-life in the body is short, roughly two to two and a half hours, and about 90% of its breakdown products leave through urine within a day.12PubMed Central. Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain Management
The trouble comes when the dose is too large. When the main detoxification pathways get saturated, more paracetamol gets funneled through the pathway that produces NAPQI. The body’s glutathione reserves run out, and the excess NAPQI starts binding to proteins inside liver cells, damaging mitochondria, increasing oxidative stress, and reducing the cell’s ability to produce energy.13Biochemistry and Biophysics Reports. Unveiling the molecular basis of paracetamol-induced hepatotoxicity: Interaction of N-acetyl-p-benzoquinone imine with mitochondrial succinate dehydrogenase This can progress to severe liver injury and, in the worst cases, liver failure. Paracetamol overdose is one of the leading causes of acute liver failure in many Western countries.
The standard antidote is N-acetylcysteine (NAC), which works not by mopping up NAPQI directly but by boosting glutathione production, replenishing the body’s own defenses against the toxic metabolite.14PubMed Central. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo NAC is highly effective when given early, which is why anyone who suspects a paracetamol overdose should seek medical help immediately rather than waiting for symptoms, since liver damage can take a day or more to become apparent.
How Well Does It Actually Work for Pain?
Paracetamol is universally recommended as a first-line option for mild pain and fever, but the evidence for some of its most common uses is weaker than many people expect. A large systematic review and meta-analysis of randomized trials found high-quality evidence that paracetamol is ineffective for low back pain, showing no meaningful improvement in pain, disability, or quality of life compared to placebo. For hip and knee osteoarthritis, the same review found that paracetamol does produce a statistically real effect on pain and disability, but the improvement is small enough that the researchers classified it as not clinically important.15PubMed Central. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials
Individual trials tell a slightly more nuanced story. A randomized trial of extended-release acetaminophen for hip or knee osteoarthritis found that a higher dose (about 4 grams a day) was superior to placebo on all primary outcome measures, though a half dose showed less consistent benefit.16PubMed. Three-month efficacy and safety of acetaminophen extended-release for osteoarthritis pain of the hip or knee: a randomized, double-blind, placebo-controlled study The overall picture is that paracetamol works for mild pain, particularly headaches, dental pain, and post-surgical discomfort, but its benefits for chronic conditions like back pain and arthritis are modest at best. For many chronic pain conditions, guidelines have increasingly shifted toward other options or combination approaches.
Paracetamol in Pregnancy
Paracetamol has long been considered the safest pain and fever medication for pregnant women, since NSAIDs carry known risks to fetal development, particularly later in pregnancy. In recent years, a wave of observational studies reported associations between prenatal paracetamol use and neurodevelopmental outcomes in children, including autism spectrum disorder and ADHD, which understandably alarmed parents and clinicians.
The evidence, however, has not held up well to closer scrutiny. A 2025 umbrella review of nine systematic reviews found that while whole-population analyses showed a possible link between maternal paracetamol use and autism or ADHD in offspring, the quality of evidence was low to critically low. When studies used sibling-controlled designs, which compare children born to the same mother and therefore share genetic and environmental backgrounds, the associations disappeared entirely.17PubMed Central. Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder in offspring: umbrella review of systematic reviews A separate 2025 systematic review and meta-analysis confirmed this pattern: sibling comparison studies showed no association between prenatal paracetamol exposure and autism, ADHD, or intellectual disability, and the absence of association persisted when only low-risk-of-bias studies were considered.18The Lancet. Prenatal paracetamol use and child neurodevelopmental outcomes: a systematic review and meta-analysis
One earlier study looking at preschool-aged children found no association between prenatal paracetamol exposure and neurodevelopmental outcomes overall, and the only signal it detected was that exposed children scored slightly lower on shyness, a finding hard to interpret as harmful.19PubMed Central. Prenatal paracetamol exposure and neurodevelopmental outcomes in preschool-aged children The current scientific consensus is that paracetamol remains the safest analgesic option during pregnancy when medication is genuinely needed, though the standard advice of using the lowest effective dose for the shortest time applies to all drugs in pregnancy.
What to Watch for in Children
Paracetamol is widely used in children and is generally safe at recommended doses, but pediatric dosing errors are a genuine hazard. Children process the drug somewhat differently than adults: the metabolic pathway that produces the toxic byproduct NAPQI matures at birth, while another major pathway takes about two years to fully develop.12PubMed Central. Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain Management In practice, the bigger risk factors for toxicity in young children are not immature liver enzymes alone but rather dosing mistakes, malnutrition, and delayed medical attention.20PubMed Central. Paracetamol Overdose in Somali Children Under Five: An Emerging Public Health Concern
Toxicity in children tends to occur at single doses roughly ten to fifteen times the recommended amount, but sustained overdosing over several days can also cause harm, especially in children under two. Real-world cases of pediatric paracetamol liver failure most often result from avoidable errors: accidental double dosing, giving doses too frequently, or unknowingly combining multiple products that each contain paracetamol (like giving a paracetamol syrup alongside a cold medicine that also contains it).12PubMed Central. Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain Management Reading labels carefully matters more with paracetamol than with almost any other over-the-counter drug, precisely because it appears in so many combination products.
Alcohol and Paracetamol
The interaction between alcohol and paracetamol is more complicated than the blanket “never mix them” warning suggests. Chronic heavy drinking can increase the risk of paracetamol-related liver injury because regular alcohol consumption upregulates the liver enzymes that convert paracetamol into the toxic metabolite NAPQI. This elevated risk persists even when paracetamol is taken shortly after the alcohol has cleared from the body. However, acute alcohol consumption, meaning a drink taken at the same time as the paracetamol, may actually inhibit the conversion of paracetamol to NAPQI, temporarily reducing the toxic pathway’s output.21PubMed Central. The role of alcohol consumption on acetaminophen induced liver injury: Implications from a mathematical model
None of this means it is safe to drink and take paracetamol casually. The protective effect of acute alcohol is a pharmacokinetic quirk, not medical advice. For anyone who drinks regularly or heavily, the chronic enzyme induction is the dominant concern, and the standard recommendation to stay well within dosing limits and avoid combining paracetamol with heavy alcohol use remains sound.
Blood Pressure Concerns
Paracetamol has traditionally been recommended over NSAIDs for people with high blood pressure, since ibuprofen and similar drugs are known to raise blood pressure and strain the kidneys. But the assumption that paracetamol is blood-pressure-neutral has been questioned. A systematic review found that some observational studies involving over 147,000 patients showed an increased risk of hypertension with paracetamol use. The randomized trial evidence was limited and inconsistent: a few small studies showed a rise in systolic blood pressure of roughly 4 mmHg, while others found no change or even a drop.22PubMed Central. A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects The evidence is far from settled, but if you are managing hypertension and taking paracetamol regularly, it is worth discussing with a doctor rather than assuming it has zero cardiovascular impact.
An Unexpected Effect on Empathy
Some of the most surprising paracetamol research has nothing to do with physical pain. In controlled experiments, participants who took paracetamol rated other people’s pain as less severe and reported less personal distress when witnessing social exclusion, compared to those who took a placebo. The effect extended to empathic concern: people on paracetamol felt less emotional warmth toward someone being ostracized and showed reduced empathy for noise-induced pain.23Social Cognitive and Affective Neuroscience. From painkiller to empathy killer: acetaminophen (paracetamol) reduces empathy for pain
This blunting is not limited to negative emotions. A separate experiment found that paracetamol reduced personal pleasure and empathic feelings when people read about positive experiences happening to others, though it did not change their ability to perceive that those experiences were positive.24PubMed Central. A Social Analgesic? Acetaminophen (Paracetamol) Reduces Positive Empathy The findings fit with the idea that physical and emotional pain share neural circuitry, and that a drug acting on one can spill over into the other. These are laboratory studies with modest effect sizes, so nobody should panic about taking paracetamol for a headache. But the results do raise interesting questions about what it means for a drug to be truly selective for physical pain when the brain does not draw a hard line between physical and social hurt.
Paracetamol in the Environment
Given the sheer volume of paracetamol consumed globally, a growing field of research has tracked what happens when the drug enters waterways through human waste. Paracetamol has been detected in rivers, coastal waters, and wastewater at concentrations high enough to concern ecotoxicologists. In laboratory experiments, marine worms exposed to environmentally relevant concentrations of paracetamol showed measurable changes in enzyme activity related to detoxification and oxidative stress, and these effects were amplified under conditions of lower seawater pH, which simulates ocean acidification trends.25PubMed Central. Assessment of Paracetamol Toxic Effects under Varying Seawater pH Conditions on the Marine Polychaete Hediste diversicolor Using Biochemical Endpoints The drug is acidic in nature, which means its absorption and toxicity in marine organisms can shift as ocean chemistry changes. Whether these laboratory findings translate to large-scale ecological harm is still an open question, but paracetamol’s status as a pharmaceutical pollutant is increasingly hard to ignore.